Notice2023-01800
Disease, Disability, and Injury Prevention and Control Special Emphasis Panel (SEP)-RFA-IP-23-002, Understanding Adult Immunization Quality Improvement Approaches Among Adult HCP and Health Departments; and RFA-IP-23-003, Programmatic Interventions To Increase Uptake of Influenza and COVID-19 Vaccination Among Students Attending Institutions of Higher Education; Amended Notice of Meeting
Primary source
Metadata and text below are from the Federal Register, a public-domain U.S. government work. Always verify the official published version before relying on it for any legal matter.
Published
January 30, 2023
Issuing agencies
Health and Human Services DepartmentCenters for Disease Control and Prevention
Full Text
<html>
<head>
<title>Federal Register, Volume 88 Issue 19 (Monday, January 30, 2023)</title>
</head>
<body><pre>
[Federal Register Volume 88, Number 19 (Monday, January 30, 2023)]
[Notices]
[Page 5882]
From the Federal Register Online via the Government Publishing Office [<a href="http://www.gpo.gov">www.gpo.gov</a>]
[FR Doc No: 2023-01800]
=======================================================================
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Centers for Disease Control and Prevention
Disease, Disability, and Injury Prevention and Control Special
Emphasis Panel (SEP)-RFA-IP-23-002, Understanding Adult Immunization
Quality Improvement Approaches Among Adult HCP and Health Departments;
and RFA-IP-23-003, Programmatic Interventions To Increase Uptake of
Influenza and COVID-19 Vaccination Among Students Attending
Institutions of Higher Education; Amended Notice of Meeting
Notice is hereby given of a change in the meeting of the Disease,
Disability, and Injury Prevention and Control Special Emphasis Panel
(SEP)--RFA-IP-23-002, Understanding Adult Immunization Quality
Improvement Approaches Among Adult HCP and Health Departments; and RFA-
IP-23-003, Programmatic Interventions To Increase Uptake of Influenza
and COVID-19 Vaccination Among Students Attending Institutions of
Higher Education; March 29-30, 2023, 10 a.m.-5 p.m. EDT,
Teleconference, Centers for Disease Control and Prevention, Room 1080,
8 Corporate Boulevard, Atlanta, Georgia, 30329, in the original FRN.
The meeting was published in the Federal Register on December 23, 2022,
Volume 87, Number 246, pages/s/78968-78969.
The meeting is being amended to remove the second day of the
meeting and should read as follows:
Date: March 29, 2023.
Time: 10 a.m.-5 p.m. (EDT).
Place: Teleconference, Centers for Disease Control and Prevention,
Room 1077, 8 Corporate Blvd., Atlanta, GA 30329.
The meeting is closed to the public.
For Further Information Contact: Gregory Anderson, M.S., M.P.H.,
Scientific Review Officer, National Center for HIV, Viral Hepatitis,
STD, and TB Prevention, CDC, 1600 Clifton Road NE, Mailstop US8-1,
Atlanta, Georgia 30329-4027; Telephone: (404) 718-8833; Email:
<a href="/cdn-cgi/l/email-protection#470006292322353428290724232469202831"><span class="__cf_email__" data-cfemail="2562644b414057564a4b654641460b424a53">[email protected]</span></a>.
The Director, Strategic Business Initiatives Unit, Office of the
Chief Operating Officer, Centers for Disease Control and Prevention,
has been delegated the authority to sign Federal Register notices
pertaining to announcements of meetings and other committee management
activities, for both the Centers for Disease Control and Prevention and
the Agency for Toxic Substances and Disease Registry.
Kalwant Smagh,
Director, Strategic Business Initiatives Unit, Office of the Chief
Operating Officer, Centers for Disease Control and Prevention.
[FR Doc. 2023-01800 Filed 1-27-23; 8:45 am]
BILLING CODE 4163-18-P
</pre><script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script></body>
</html>Indexed from Federal Register on January 30, 2023.
This is legal information, not legal advice. Laws vary by jurisdiction and change frequently. Always verify current law with official sources and consult a licensed attorney in your jurisdiction for advice on your specific situation.